NOVT Earnings

NOVT reported its earnings on 2026-05-11, showcasing a revenue of against an estimate of 252.44M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.77 by 0%. The stock experienced a 13.72% price change on the earnings day and a 9.29% change over the next five days, reflecting market reactions to the results.

Following NOVT's earnings announcement on 2026-05-11, the stock price moved by 13.72% on the day of the release. Over the subsequent five days, it saw a 9.29% change. Historically, NOVT's stock price tends to shift by an average of 4.05% in the 10 days leading up to earnings and 3.82% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate NOVT's annual revenue to reach 260.30M, while the EPS is projected at 0.88. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between NOVT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, NOVT's stock price typically moves by 4.05% in the 10 days before its earnings and 3.82% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 0.88 and revenue of 260.30M.

The earnings call and Q&A reveal a positive outlook for Novanta. Despite a slight decline in gross margin, strong growth is evident in multiple segments, such as Medical Solutions and Automation Enabling Technologies. The company's strategic initiatives, including regionalization and new product launches, are expected to drive future growth. The NVIDIA AI lab certification and strong bookings further bolster confidence. Although some uncertainties remain, particularly in cost management, the overall sentiment is optimistic, suggesting a likely stock price increase of 2% to 8% over the next two weeks.